LAMISIL
LOE ApproachingNDAORALTABLET
Approved
May 1996
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
1
Data completeness
2/8 — Basic
Drug data last refreshed Yesterday
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
LAMISIL (terbinafine hydrochloride) is an oral small-molecule antifungal approved in 1996 for tinea pedis (athlete's foot). It is a non-azole fungistatic agent that inhibits fungal squalene epoxidase, disrupting ergosterol synthesis in fungal cell membranes. The drug represents a distinct mechanism from competing azole antifungals in the tinea treatment space.
LOE Approaching
Product is in LOE phase with moderate competitive pressure (30/100), indicating declining brand support and downsizing commercial infrastructure.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (1)
Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment
30 enrolled
Candidiasis, OralHIV Infections
Career Relevance
LAMISIL oral has zero linked job openings, reflecting its LOE status and minimal commercial investment. Career opportunities on this product are primarily defensive—cost management, generic transition support, and market share stabilization rather than growth initiatives.
Brand Manager
Worked on LAMISIL at Novartis? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.